A phase I study of docetaxel and 5-fluorouraciI in patients with advanced solid malignancies

This publication has 14 references indexed in Scilit:

• A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
  British Journal of Cancer, 1998
• Docetaxel.
  Journal of Clinical Oncology, 1995
• Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I
  Anti-Cancer Drugs, 1995
• Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
  Journal of Clinical Oncology, 1995
• Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group
  British Journal of Cancer, 1994
• Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
  Journal of Clinical Oncology, 1994
• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: Reversibility, ligand stoichiometry, and competition
  Biochemistry, 1993
• Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
  JNCI Journal of the National Cancer Institute, 1991